GPBAR1 and familial dilated cardiomyopathy: By engaging TGR5 signaling, INT-777 reduces cardiac lipid deposition, attenuates cardiomyocyte lipotoxicity, and impedes DCM progression—demonstrating significant therapeutic potential.